AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital. It has a research and development collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Metrics to compare | AFT | Peers Peers - average of corresponding metrics from companies closely matching AFT: BLT, RUA, 4540, SQURPHARMA, JSP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAFTPeersSector |
---|---|---|---|---|
P/E Ratio | 27.7x | 16.7x | −0.7x | |
PEG Ratio | −1.07 | 0.50 | 0.00 | |
Price/Book | 3.4x | 1.7x | 2.6x | |
Price / LTM Sales | 1.6x | 1.6x | 3.4x | |
Upside (Analyst Target) | 18.8% | 25.8% | 37.6% | |
Fair Value Upside | Unlock | 20.8% | 5.3% | Unlock |